BioCryst Pharmaceuticals Revenue

In the year 2024, BioCryst Pharmaceuticals had annual revenue of $450.71M USD with 36.00% growth. BioCryst Pharmaceuticals had revenue of $131.53M in the quarter ending December 31, 2024, with 40.83% growth.

Revenue

$450.71M

Revenue Growth

+36.00%

P/S Ratio

3.91

Revenue / Employee

$777.09K

Employees

580

Market Cap

36.75B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	450.71M	119.30M	36.00%
Dec 31, 2023	331.41M	60.59M	22.37%
Dec 31, 2022	270.83M	113.66M	72.31%
Dec 31, 2021	157.17M	139.36M	782.38%
Dec 31, 2020	17.81M	-31.02M	-63.53%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Wal-Mart de México	972.31B
Grupo Financiero Banorte	131.20B
Arca Continental	245.87B
GMéxico Transportes	61.50B
FIBRA Prologis	11.80B
Fibra UNO	29.47B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	18.37B
Quálitas Controladora	68.08B

Revenue Rankings